Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Seagen Inc.
Elevation Oncology
Universitair Ziekenhuis Brussel
M.D. Anderson Cancer Center
St. Luke's-Roosevelt Hospital Center